Search - tctmd.com

Displaying 1 - 20 of 91

Sort: Relevancy | Date

LBBB Remains Problematic 1 Year Post-TAVI: TVT Registry

News Daily News

LBBB Remains Problematic 1 Year Post-TAVI: TVT Registry

Yael L. Maxwell

January 07, 2026

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

News Conference News TCT 2025

PARTNER 3 at 7 Years: Stable Outcomes, No Signs of Valve Failure With TAVI

Michael O'Riordan

October 27, 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

News Conference News TCT 2025

More Data on Tricuspid Valve Interventions Reassure, yet Questions Remain

Yael L. Maxwell

October 26, 2025

TTVR Remains Safe, Effective in Presence of CIED Leads

News Conference News TCT 2025

TTVR Remains Safe, Effective in Presence of CIED Leads

October 25, 2025

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

News Features

Imperfect Evidence: How Strong Is the Case for Transcatheter Tricuspid Valve Interventions?

October 22, 2025

September 2025 Dispatch for the CV Team

News Opinion CV Team Dispatch

September 2025 Dispatch for the CV Team

September 30, 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Yael L. Maxwell

July 03, 2025

Solid, Early Surgical Results With Polymer Mitral Valve

News Conference News NY Valves 2025

Solid, Early Surgical Results With Polymer Mitral Valve

July 02, 2025

Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL

News Conference News NY Valves 2025

Changes in Quality of Life Mirror TR Reductions After Tricuspid Procedures: Tri-QOL

Yael L. Maxwell

July 01, 2025

Global Burden of Degenerative Mitral Valve Disease Continues to Rise

News Conference News NY Valves 2025

Global Burden of Degenerative Mitral Valve Disease Continues to Rise

June 30, 2025

No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI

News Conference News ESC Heart Failure 2025

No Additional Gain in Quality of Life With Dapagliflozin on Top of TAVI

May 20, 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

News Conference News ACC 2025

By 2 Years, Tricuspid TEER Reduces Hospitalizations for HF: TRILUMINATE

Michael O'Riordan

March 31, 2025

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

News Daily News

One-Year Mortality With TAVI Rose in Recent Years: TVT Registry

March 25, 2025

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

News Daily News

Patient-Centric Outcomes Embraced by Global Heart Valve Experts

February 24, 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

News Conference News THT 2025

Questioning the KCCQ: Experts Debate Its Validity as QoL Metric

February 19, 2025

STS Experts Tackle Need For Women-Only Trials in Surgery

News Conference News STS 2025

STS Experts Tackle Need For Women-Only Trials in Surgery

Yael L. Maxwell

January 29, 2025

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

News Conference News TCT 2024

TRISCEND II: Full Results a Win for TTVR in Severe Tricuspid Regurgitation

Michael O'Riordan

October 30, 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

News Conference News TCT 2024

TRILUMINATE: More Patient Data Reassure on TEER’s Benefits for Severe TR

Michael O'Riordan

October 29, 2024

TCT 970: Cost and Healthcare Utilization by Age, Sex, and Race in the Years Leading Up to a Severe or Clinically Significant Status for Patients With Tricuspid Regurgitation

Presentation TCT 2024

TCT 970: Cost and Healthcare Utilization by Age, Sex, and Race in the Years Leading Up to a Severe or Clinically Significant Status for Patients With Tricuspid Regurgitation

Presenter: Colin Barker

October 29, 2024

TCT 832: Impact of Coronary Artery Disease and Revascularization on Clinical and Health Status Outcomes After TAVR: Results From the STS/ACC TVT Registry

Presentation TCT 2024

TCT 832: Impact of Coronary Artery Disease and Revascularization on Clinical and Health Status Outcomes After TAVR: Results From the STS/ACC TVT Registry

Presenter: Yasser Sammour

October 29, 2024

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.